Expedito Luna – Infectious Diseases Vaccines – Best Researcher Award

Posted on by Infectious

Expedito Luna - Infectious Diseases Vaccines - Best Researcher Award

USP - Brazil

AUTHOR PROFILE

ORCID

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

PROFESSIONAL ENDEAVORS 🏥

Dr. Expedito J.A. Luna’s professional trajectory is marked by decades of service in Brazil’s public health system. He began his work at the State of São Paulo Health Secretariat and later served at the Municipal Health Secretariat. His career then advanced to the national level, where he became Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health. In these roles, he was instrumental in implementing large-scale epidemiological programs targeting vaccine-preventable illnesses and neglected tropical diseases. He brought a scientific mindset and operational discipline to the management of epidemics, working to integrate surveillance, diagnostics, and vaccine strategies. His efforts had a measurable impact on national health metrics, especially in reducing the burden of diseases through expanded immunization campaigns. He also served as a scientific advisor to national STI and AIDS programs, showing the breadth of his public health influence. These professional chapters reflect his commitment to translating data into action and policy. Throughout his career, he has emphasized the importance of scientific evidence in health decision-making, especially around Infectious Diseases Vaccines, which he consistently promoted as a cornerstone of disease prevention and control strategies across Brazil’s healthcare infrastructure.

RESEARCH EXCELLENCE & FOCUS 🔬

A cornerstone of Dr. Luna’s legacy is his prolific research in epidemiology, with a particular focus on vaccine effectiveness and disease surveillance. His academic base at the Institute for Tropical Medicine at the University of São Paulo has been a launchpad for numerous groundbreaking studies. From COVID-19 and dengue to influenza and Zika, he has led or participated in over 30 funded research projects. His investigations often center on the real-world effectiveness of Infectious Diseases Vaccines, including CORONAVAC, influenza, rotavirus, yellow fever, and tetravalent dengue vaccines. He has received grants from esteemed institutions such as FAPESP, CNPq, the Ministry of Health, and international organizations like the Mérieux Foundation and Sanofi. Many of his studies use test-negative case-control designs or cohort approaches to measure vaccine performance in diverse populations, including healthcare workers, pregnant women, and indigenous communities. His work bridges field epidemiology with laboratory science, often addressing disease prevalence, transmission dynamics, and immunological response. Dr. Luna’s research not only advances academic knowledge but also informs national immunization policies. With hundreds of peer-reviewed publications, his data-driven insights have reinforced the critical role of Infectious Diseases Vaccines in managing Brazil’s—and the region’s—public health challenges.

POLICY INFLUENCE & LEADERSHIP 📊

Dr. Luna has played a pivotal role in shaping Brazil’s public health policy, particularly in infectious disease control and immunization programs. His tenure as Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health was marked by significant advancements in national disease prevention strategies. He oversaw large-scale surveillance systems and contributed to the development and evaluation of national vaccine policies, ensuring their alignment with scientific findings. His leadership was vital in coordinating efforts to contain outbreaks of dengue, influenza, Zika, and other emerging threats. He also contributed to global discussions on vaccine strategy and safety, as seen in his co-authorship of influential papers on post-licensure vaccine evaluation. His guidance extended to the National Vaccine Coverage Survey and maternal vaccination initiatives, which were instrumental in protecting vulnerable groups. Dr. Luna's ability to bridge academia and policy-making set a gold standard for evidence-based governance. His focus on Infectious Diseases Vaccines positioned him as a trusted voice in both domestic and international forums. Through his leadership, Brazil has seen greater coherence between scientific discovery and public health application, enhancing the reach and effectiveness of vaccination as a tool for disease control.

TEACHING & MENTORSHIP 📚

Beyond his public health and research contributions, Dr. Luna has nurtured the next generation of epidemiologists as a professor at the University of São Paulo’s Institute for Tropical Medicine. Since 2008, he has played an integral role in training medical students, public health professionals, and postgraduate scholars in infectious disease epidemiology. His courses emphasize critical thinking, data interpretation, and the application of epidemiological methods to real-world problems. He brings field experience into the classroom, enriching academic learning with practical insights. Dr. Luna also mentors young researchers through thesis supervision and research collaboration, many of whom now hold influential positions in public health across Brazil. He is renowned for promoting interdisciplinary learning, encouraging students to explore links between clinical outcomes, environmental factors, and population health. Central to his pedagogy is the pivotal role of Infectious Diseases Vaccines in disease prevention. His mentorship approach is not only academic but also aspirational, instilling a sense of duty and purpose among his mentees. Through his teaching, Dr. Luna ensures that the values of scientific rigor, public health advocacy, and vaccine equity continue to influence Brazil’s healthcare landscape for years to come.

RECOGNITION & ACCOLADES 🏆

Throughout his distinguished career, Dr. Expedito J.A. Luna has earned widespread recognition for his contributions to public health and epidemiology. His efforts have been celebrated not just within Brazil but also in international forums, owing to his collaborative work with organizations like the World Health Organization, Pan American Health Organization, and various global health research foundations. His publications in high-impact journals, ranging from The Lancet to Vaccine and BMJ Open, underscore the scholarly depth and policy relevance of his work. As a principal investigator on critical national studies, including those assessing vaccine coverage, effectiveness, and disease prevalence, Dr. Luna has received prestigious research grants and institutional support across decades. His influence has been instrumental in developing and evaluating policies that continue to shape national immunization strategies. Among his most valuable recognitions is the trust placed in him by Brazil’s Ministry of Health to direct nationwide programs during times of crisis. Across all honors, one theme remains consistent: his unwavering commitment to advancing Infectious Diseases Vaccines as a primary defense against public health threats. Dr. Luna’s accolades are a testament to his lasting impact on science, policy, and population health.

IMPACT & GLOBAL COLLABORATION 🌎

Dr. Luna’s work transcends borders, exemplifying the global nature of public health. Through cross-national research collaborations and policy consulting, he has contributed to a broader understanding of how infectious diseases emerge, spread, and can be controlled through vaccination. His involvement in studies on dengue, influenza, and COVID-19 has provided comparative insights applicable across Latin America and beyond. He has co-authored international papers addressing vaccine strategies, transmission models, and post-licensure evaluations. Dr. Luna’s voice is regularly sought in global forums focused on Infectious Diseases Vaccines, where he shares Brazil’s experiences and learns from global peers. His collaboration with organizations like WHO and PAHO has influenced vaccine rollout strategies and disease surveillance models. He also contributes to international training programs, strengthening capacity in low-resource settings. By advocating for equitable vaccine access and evidence-based interventions, Dr. Luna has helped shape a more unified and proactive global public health response. His legacy extends to influencing vaccine policies not only in Brazil but in other countries that have modeled their strategies after his data-driven approaches. Through this global footprint, he reinforces the indispensable role of Infectious Diseases Vaccines in achieving worldwide health security.

LEGACY & FUTURE VISION 🔮

As Dr. Luna continues his work at the University of São Paulo, his vision for the future remains grounded in scientific advancement and public health equity. He envisions a world where data-driven policies, robust surveillance, and universal access to effective vaccines are the norm rather than the exception. His ongoing projects focus on vaccine effectiveness, particularly for COVID-19 and dengue, reaffirming his belief in the central role of Infectious Diseases Vaccines in combating evolving health threats. He remains deeply involved in guiding young scientists and contributing to research that influences national immunization programs. Looking ahead, he advocates for stronger integration of epidemiological data with digital health tools to improve outbreak detection and response. His legacy lies not only in the programs he helped build or the research he led but also in the public health mindset he helped instill in Brazil and beyond. By continuing to engage with policy-makers, research bodies, and students, Dr. Luna ensures that the next generation will carry forward the torch of scientific integrity and vaccine-driven disease control. His work serves as a blueprint for future epidemiologists seeking to leverage Infectious Diseases Vaccines for a healthier, more resilient world.

NOTABLE PUBLICATION 

  • Title: A spatial case-control study on symptomatic and inapparent primary dengue infections in an endemic city in Brazil
    Authors: Gerusa Figueiredo, Francisco Chiaravalloti, Sérgio Campos, Alessandra Cristina Guedes Pellini, Alvina Clara Felix, Expedito Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Detection of Internal Transcribed Spacer 1 and hsp70 Genetic Markers Using Restriction Fragment Length Polymorphisms and Sequencing in Identification of Leishmania Species Causing Tegumentary Leishmaniasis in Brazil
    Authors: J.A. Delprete, L.V. de Almeida, A.M. Barros, R.D.C. Soler, A.A. Bittencourt, E.J. de Albuquerque Luna, J.A.L. Lindoso, L.M.A. Braz
    Journal: American Journal of Tropical Medicine and Hygiene
    Year: 2024

 

  • Title: Dynamics of communication on measles vaccination on digital platforms in the Brazilian context: challenges and perspectives
    Authors: Maria da Penha Soares Silva, Vera Lúcia Gattás, Expedito José de Albuquerque Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Low vaccine coverage and varicella outbreaks in Brazil − 2019–2022
    Authors: D.M. Fujita, L.H. da Silva Nali, R.R. da Costa, H.F. de Andrade Júnior, E.J. de Albuquerque Luna
    Journal: Vaccine
    Year: 2024

 

  • Title: Phylogenetics, Epidemiology and Temporal Patterns of Dengue Virus in Araraquara, São Paulo State
    Authors: C.S. de Souza, G.S. Caleiro, I.M. Claro, J.G. de Jesus, T.M. Coletti, C.A.M. da Silva, Â.A. Costa, M. Inenami, A.C. Ribeiro, A.C. Felix et al.
    Journal: Viruses
    Year: 2024

Moncef Chouaibi – Treatment for Infectious Diseases – Best Academic Researcher Award

Posted on by Infectious

Moncef Chouaibi - Treatment for Infectious Diseases - Best Academic Researcher Award 

Higher School of Food Industries of Tunis - Tunisia

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Professor Moncef Chouaïbi's academic journey reflects a strong foundation in mathematical sciences and food engineering. He began with a Bachelor of Mathematics from 1996 to 2000, which laid the groundwork for his analytical approach in later scientific explorations. He pursued an engineering diploma, master’s, and ultimately a PhD in Food Industries between 2000 and 2013 from the University of Carthage and the University of Salerno. His doctoral studies focused on food engineering and preservation technologies, critical to public health, especially in regions facing foodborne infections. During these formative years, he developed a keen interest in the optimization of extraction processes, thermal food treatment, and encapsulation of bioactive compounds—techniques that today underpin innovations in antimicrobial food systems. His early academic path emphasized both theoretical mastery and applied research, equipping him with the scientific literacy and lab-based expertise to address complex problems in food safety and infectious disease management. His studies incorporated methodologies that enhance food functionality while limiting pathogen transmission—a core concern in infectious disease control. This period was not just a phase of learning but also a springboard for his later contributions to microbiologically safe and nutritionally enhanced food products.

🧪 PROFESSIONAL ENDEAVORS IN FOOD SCIENCE

Since the early stages of his career, Professor Chouaïbi has devoted himself to the advancement of food engineering with a strong focus on safety, stability, and nutrition. Starting as a Senior Research Fellow in Tunis and later in Salerno, Italy, he quickly transitioned into academic leadership as an Assistant Professor and eventually as a full Professor at the Higher School of Food Industries of Tunis. His teaching and mentoring have supported a new generation of scientists, but it is his research that sets him apart. He has actively explored the use of natural preservatives, bioactive components, and rheological food properties to improve food quality and safety. This work is especially relevant in developing countries where infectious diseases are often exacerbated by compromised food systems. By modeling heat and mass transfer, Professor Chouaïbi has helped design preservation techniques that reduce microbial load in food, directly contributing to infectious disease prevention. He has also collaborated with biotechnology and food chemistry experts to create functional foods that boost immune responses. His hands-on approach and strategic focus on real-world applications of food science make his professional journey a beacon for interdisciplinary innovation in nutrition and public health.

🧬 RESEARCH ON FUNCTIONAL FOODS & BIOACTIVE COMPOUNDS

Professor Moncef Chouaïbi has established himself as a pioneering researcher in the field of functional foods and bioactive compound extraction. His studies on antioxidant-rich oils, including those derived from pumpkin, celery, and Zizyphus lotus, demonstrate his commitment to exploring nature-derived solutions to public health challenges. Many of these compounds, such as polyphenols and flavonoids, have demonstrated antimicrobial and antiviral properties, making them potential adjuncts in infectious disease treatment. His innovative work on encapsulation technology—particularly nanoemulsions and double emulsions—has enabled targeted delivery of these compounds, enhancing their stability and efficacy. These advances have broad implications in the management of bacterial and viral foodborne illnesses, especially in vulnerable populations. His research is widely published in high-impact journals, evidencing both depth and breadth. Through projects like yogurt fortified with inulin or camel milk enhanced with probiotics, he combines scientific rigor with nutritional foresight. His exploration of shelf-life enhancement and preservation methods directly addresses contamination and disease spread in perishable goods. Such applications play a crucial role in food systems resilience against pathogens, including those that cause enteric infections. His work positions food not only as sustenance but as a strategic platform for disease intervention.

🧫 ADVANCES IN INFECTIOUS DISEASE TREATMENT VIA FOOD SCIENCE

Professor Chouaïbi's contributions have extended beyond traditional food science into the realm of infectious disease treatment and prevention. His application of bioactive-rich emulsions and coatings—such as thyme essential oil encapsulation and almond gum films—offers a sustainable, chemical-free alternative to conventional disinfectants. These formulations are especially effective against microbial spoilage and contamination, which are common vectors for infectious disease transmission through food. His collaborations have resulted in yogurt enriched with antimicrobial agents and functional cheeses with targeted probiotic properties, both of which support gastrointestinal health and immunological defense. His work on modeling urease activity reduction in soybean meals and optimizing drying processes has clinical relevance in reducing pathogen viability. Furthermore, his patents on emulsifiers and encapsulation systems are setting new standards in controlled delivery of anti-pathogenic agents. As diseases evolve and antibiotic resistance grows, the integration of food engineering in the fight against infections becomes increasingly vital. Through his food-based biotechnological innovations, Professor Chouaïbi is contributing practical tools that align nutrition with infection control, reinforcing the interdisciplinary bridge between food technology and public health.

📚 EDITORIAL AND SCHOLARLY IMPACT

Beyond research and teaching, Professor Chouaïbi holds influential editorial roles in several international journals including Discover Food, Journal of Food Measurement and Characterization, and Frontiers in Materials. These positions affirm his global recognition as an authority in food engineering. His role as guest editor and board member enables him to shape emerging discourses around sustainable food systems, food safety, and biofunctional ingredients. He has authored multiple books and book chapters that explore food preservation technologies, phytochemicals, and encapsulation techniques—many of which serve as reference texts in food and nutrition science. His scholarly contributions provide critical frameworks for understanding how food technology can mitigate microbial risks. Through peer review and journal leadership, he fosters innovation, ensures scientific rigor, and promotes cross-border collaborations. This academic leadership enhances not just his personal standing but also the integrity and visibility of food science research in developing infectious disease interventions. By mentoring young scientists and influencing research directions globally, Professor Chouaïbi multiplies his impact, ensuring the continuity and evolution of science-based solutions to pressing health threats.

🏆 HONORS, PATENTS & INTERNATIONAL COLLABORATIONS

Professor Moncef Chouaïbi’s excellence has been acknowledged through various honors, patents, and extensive international engagements. He is a patent holder for technologies including novel emulsifiers for drug delivery and food coating systems with bioactive properties, which support food safety and infectious disease mitigation. These innovations provide scalable solutions for controlling contamination in food supply chains. His scientific influence spans across borders with collaborative research in Italy, Japan, and across North Africa. Participation in international conferences—from the Euro-Global Conference on Food Science to Japan-Tunisia symposia—underscores his reputation as a global expert. His patented work on the use of natural polymers and biopolymers in preserving food integrity has found use in both academic and industrial settings. These achievements not only validate his research but also position his methodologies as models for innovation in developing antimicrobial systems from food matrices. His multidisciplinary patents have crossover value in pharmaceuticals, nutraceuticals, and environmental safety. These accolades represent the fusion of his engineering ingenuity with a vision for healthier communities.

🌍 LEGACY & FUTURE CONTRIBUTIONS TO GLOBAL HEALTH

Looking ahead, Professor Chouaïbi is poised to further integrate food engineering with global health initiatives. His future research aims to refine nanoencapsulation methods to deliver targeted nutritional therapies and anti-infective agents through everyday food products. His commitment to addressing malnutrition, microbial contamination, and diet-related diseases aligns with global health goals and sustainable development frameworks. By developing bioactive-rich ingredients from agricultural waste, he also promotes circular economy principles and food system sustainability. His work resonates deeply in low- and middle-income countries, where accessible, nutrition-based interventions are critical in combating infectious disease burdens. As a mentor and innovator, his legacy will extend through the scientists he inspires, the institutions he shapes, and the communities that benefit from his science. With over 50 peer-reviewed articles and involvement in cutting-edge international projects, Professor Chouaïbi's contribution to the intersection of food science and infectious disease control is both transformative and enduring. His vision positions food not just as nourishment, but as a strategic frontier in the fight against infectious diseases worldwide.

NOTABLE PUBLICATION

  • Title: Co-encapsulation of catechin and L-lysine in water-in-oil-in-water (W1/O/W2) double emulsion using membrane emulsification process: application in carrot based infant-purée
    Authors: Eya Soussi, Nayrouz Yahyaoui, Moncef Chouaibi, Salem Hamdi
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Comparative study of Acacia tortilis subsp. raddiana gum of Tunisian origin and commercial Acacia senegal gum
    Authors: Khouloud Rigane, Moncef Chouaibi, Romdhane Karoui
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Arbutus unedo fruit syrup as a fortifying agent: effect on physicochemical, microbiological, rheological, sensory and antioxidant properties of yoghurt
    Authors: I. Essaidi, M. Chouaibi, H. Haj Koubaier, S. Bouacida, A. Snoussi, Y. Abassi, N. Bouzouita
    Journal: Journal of Food Science and Technology
    Year: 2023

 

  • Title: Bioactive Phytochemicals from Pumpkin Seed Oil Processing By-products
    Authors: L. Rezig, K. Gharsallah, M. Chouaibi
    Journal: Reference Series in Phytochemistry (Book Chapter)
    Year: 2023

 

  • Title: Influence of Conservation Agriculture on Durum Wheat Grain, Dough Texture Profile and Pasta Quality in a Mediterranean Region
    Authors: I. Kerbouai, D. Sfayhi, K. Sassi, H.C. M’hamed, H. Jenfaoui, J. Riahi, S. Arfaoui, M. Chouaibi, Ben-... (author name appears truncated)
    Journal: Agriculture (Switzerland)
    Year: 2023

Mohamed Abdel-Rahim – Zoonosis – Best Researcher Award

Posted on by Infectious

Mohamed Abdel-Rahim - Zoonosis - Best Researcher Award

National Institute of Oceanography and Fisheries (NIOF) - Egypt

AUTHOR PROFILE 

ORCID

🌊 ACADEMIC FOUNDATION IN AQUATIC SCIENCE

Dr. Mohamed M. Abdel-Rahim laid the bedrock of his scientific journey at the University of Alexandria, where he earned his B.Sc., M.Sc., and Ph.D. in Aquaculture with distinction. With a persistent drive for excellence, his educational background immersed him in marine biology, aquaculture systems, and aquatic animal health—fields critical for understanding zoonotic risks in aquatic environments. His early research explored aquaculture engineering and fish reproduction, equipping him with both technical mastery and biological insight. This academic rigor formed the foundation for his future contributions to the management of aquatic ecosystems, fish diseases, and food safety, which are all central to zoonosis prevention in aquaculture. As zoonotic diseases increasingly emerge from aquatic sources due to intensified aquaculture practices, Dr. Abdel-Rahim’s work in environmental monitoring, hatchery design, and water quality management positions him as a vital player in sustainable fish production and health risk mitigation. Through advanced courses in Spain and France, he also honed his understanding of environmental impacts and modern aquaculture technologies. This academic foundation allowed him to interface between ecosystem health and public safety, setting the stage for lifelong contributions to aquaculture science and zoonotic disease control in aquatic systems.

🔬 SCIENTIFIC INNOVATIONS AND RESEARCH PURSUITS

Dr. Mohamed M. Abdel-Rahim’s research legacy is marked by groundbreaking innovations in sustainable aquaculture and aquatic health, focusing on preventing zoonosis through improved farming systems. As Principal Investigator and team member on numerous projects funded by NIOF and international bodies, he has tackled challenges in marine aquaculture, water purification, biofloc technology, and fish nutrition. Notably, his work on recirculating aquaculture systems (RAS) and Integrated Multi-Trophic Aquaculture (IMTA) models highlights his role in minimizing the environmental and biological risks that contribute to zoonotic transmission. His peer-reviewed publications—over 55 in high-impact journals—span topics from bacterial load reduction to the use of herbal immunostimulants and probiotics in fish diets, directly addressing disease resistance and food safety. Dr. Abdel-Rahim’s focus on fish health and immunity builds a crucial bridge to zoonotic disease prevention, especially in densely stocked aquatic farms where pathogen transfer between species and humans is possible. His use of natural additives and innovative feed strategies further ensures healthier aquaculture products, aligning food security with public health. These contributions are not just technical—they’re visionary, establishing protocols that integrate sustainability, economics, and zoonotic risk reduction within modern aquaculture systems.

🧪 EDUCATION AND TRAINING IMPACT

Through over 75 national and international lectures and 10 years of university teaching, Dr. Mohamed M. Abdel-Rahim has transformed aquaculture education in Egypt and abroad. His curriculum covers fish hatchery management, marine aquaculture systems, and environmental engineering, with a strong emphasis on biosafety—a core element in zoonosis control. He has taught and developed more than ten specialized aquaculture courses across Alexandria, Kafrelsheikh, and Suez Canal Universities, including postgraduate programs in fish disease management and hatchery design. Internationally, he has trained scientists in Senegal, South Africa, and other African countries under African Union projects like ITACA, sharing practical skills and theoretical knowledge to bolster regional aquaculture resilience against zoonotic threats. His commitment to capacity building is evident in his supervision of 23 master’s and PhD theses, many of which address water quality, disease resistance, and biosecurity. By emphasizing preventive practices and sustainable systems, he nurtures a new generation of scientists equipped to face the rising zoonotic risks tied to aquatic food production. His work bridges the gap between education, practice, and global health, empowering students and professionals to create safer, healthier aquaculture ecosystems worldwide.

🧬 ZOONOSIS PREVENTION THROUGH AQUACULTURE SYSTEMS

In Dr. Abdel-Rahim’s extensive aquaculture research, zoonosis prevention is not an afterthought—it is a structural priority. His pioneering application of recirculating and integrated aquaculture systems directly contributes to reducing disease transmission across species boundaries, a vital measure in managing zoonotic threats. These systems, particularly his solar-powered R-IMTA model, are designed to enhance water quality, reduce pathogen loads, and minimize human exposure to harmful aquatic pathogens. His work on bioremediation—using probiotics, natural zeolites, and medicinal plants—improves not only fish performance but also public health safety. His studies on feed additives like saponins, nucleotides, and bentonite highlight how tailored nutrition can strengthen fish immunity and reduce the need for antibiotics, a key factor in controlling antimicrobial resistance—another zoonosis-related concern. Dr. Abdel-Rahim’s scientific contributions propose real-world solutions that address both aquaculture productivity and emerging public health risks. His integrated approach ensures that aquaculture is not just economically viable, but also ecologically sound and safe for human consumption. This makes his research a cornerstone in the global effort to understand and prevent aquatic-based zoonoses, especially in the face of increasing demand for fish protein and the intensification of fish farming practices.

🏆 HONORS, PUBLICATIONS, AND GLOBAL RECOGNITION

Dr. Mohamed M. Abdel-Rahim’s distinguished career is adorned with awards, global lectures, and editorial roles, underscoring his position as a world leader in aquaculture and zoonosis-aware research. He has published in more than 50 peer-reviewed journals, many in Q1-ranked outlets such as Aquaculture, Scientific Reports, and Aquaculture International, often addressing immune responses, water quality, and aquafeed innovations—all key to reducing zoonotic threats in fish production. With multiple roles as a journal reviewer and editorial board member for esteemed publications, including PLOS ONE, Marine Drugs, and Journal of Cleaner Production, he influences global research quality and direction. His H-index, tracked across Web of Science, Scopus, and Google Scholar, reflects the scientific weight of his contributions. He has delivered impactful presentations across Africa and Europe, notably at the UN Environment-MED POL regional working groups and African Union conferences. These platforms have enabled him to advocate for sustainable, biosecure aquaculture systems that prioritize public health. Whether supervising PhD candidates or guiding governmental policy discussions, Dr. Abdel-Rahim's accolades reflect his unwavering commitment to science, sustainability, and zoonotic disease prevention.

🌍 IMPACT ON SUSTAINABLE AQUACULTURE DEVELOPMENT

Dr. Abdel-Rahim’s impact on sustainable aquaculture in Egypt and beyond is deeply rooted in his implementation of technologies that align environmental stewardship with public health, particularly in mitigating zoonosis. As a former director and scientific supervisor at El-Max Station for Applied Research, he championed eco-innovative farming practices, integrating marine hatcheries with IMTA models to ensure minimal waste, disease containment, and species welfare. His feasibility studies for international aquaculture investments prioritize biosecurity and environmental harmony, advocating integrated solutions for shrimp, fish, and bivalves farming. His consultancies with companies like Silk Stevens Ltd. and Evergreen United exemplify his ability to bridge academic insight with commercial application, ensuring that food systems remain productive without increasing zoonotic exposure. He routinely collaborates with policymakers and environmental agencies to design training programs that embed principles of biosafety and zoonotic surveillance into national aquaculture strategies. Through his cross-sectoral efforts, Dr. Abdel-Rahim has become a pivotal figure in harmonizing productivity with ecological balance—advancing aquaculture not only as a food system but as a public health safeguard in the face of climate change and emerging zoonotic diseases.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Mohamed M. Abdel-Rahim’s legacy is one of foresight, resilience, and a steadfast commitment to integrating zoonosis prevention into every facet of aquaculture. With over three decades of scientific and educational experience, his blueprint for the future focuses on interdisciplinary collaborations and next-generation aquaculture systems that actively mitigate zoonotic risks. His future contributions aim to enhance molecular-level monitoring of pathogens, apply artificial intelligence to aquaculture biosurveillance, and expand the role of nutraceuticals in fish diets to reduce antibiotic dependence. His ongoing supervision of PhD and master’s theses ensures continuity in research that bridges ecological sustainability with public health. Through expanding training programs, he seeks to arm future scientists with the tools necessary to respond to pandemics that may emerge from aquatic environments. Furthermore, Dr. Abdel-Rahim envisions regional centers of excellence in North Africa for zoonosis monitoring in aquaculture, capitalizing on Egypt’s strategic position in global fish trade. His work is a testament to the principle that aquaculture, when responsibly managed, can be a frontline defense against zoonotic spillovers—reinforcing his enduring influence on both science and society.

NOTABLE PUBLICATION

  • Title: Replacing fishmeal with Palaemon serratus meal enhances growth, carcass traits, digestive enzymes, immune-physiological response, antioxidants, and inner organ histopathology of Dicentrarchus labrax
    Authors: Toqa S. M. Saif, Hatem H. Mahmoud, Ashraf I. G. Elhetawy, Reda M. Fahim, Hosam E. Elsaied, Mohamed M. Abdel-Rahim
    Journal: Aquaculture International
    Publication Date: October 2025

 

  • Title: Correction to: The effect of aqueous application of probiotics on growth, heavy metal accumulation, blood biochemistry, and histological alterations of Dicentrarcus labrax
    Authors: Mohamed M. Abdel‑Rahim, Shimaa A. Shahin, Abdallah Tageldein Mansour, Ahmed Saud Alsaqufi, Ahmed E. Elshafey, Amira A. Omar, Hassan A. El‑Sharkawy, Radi A. Mohamed, Ashraf I. G. Elhetawy
    Journal: Aquaculture International
    Publication Date: June 2025

 

  • Title: Integrated aquaculture of whiteleg shrimp Litopenaeus vannamei and European seabass Dicentrarchus labrax: impacts on performance, welfare, blood physiological response, carcass traits, productivity, and farm profitability
    Authors: Ashraf I. G. Elhetawy, Abdallah Tageldein Mansour, Ayman M. Lotfy, Ahmed I. A. Mansour, Shimaa A. Shahin, Mohamed M. Zayed, Ghada R. Sallam, Mohamed M. Abdel-Rahim
    Journal: Aquaculture International
    Publication Date: June 2025

 

  • Title: The effect of aqueous application of probiotics on growth, heavy metal accumulation, blood biochemistry, and histological alterations of Dicentrarcus labrax
    Authors: Mohamed M. Abdel-Rahim, Shimaa A. Shahin, Abdallah Tageldein Mansour, Ahmed Saud Alsaqufi, Ahmed E. Elshafey, Amira A. Omar, Hassan A. El-Sharkawy, Radi A. Mohamed, Ashraf I. G. Elhetawy
    Journal: Aquaculture International
    Publication Date: April 2025

 

  • Title: Effect of the bipolar aluminum electrocoagulation model (BAEM) on heavy metal concentration, growth, immunological response, and parasitic activity in cultured Dicentrarchus labrax in underground seawater
    Authors: Amr Fadel, Abeer A. Moneer, Khaled M. Abdelsalam, Mohamed M. Abdel-Rahim
    Journal: Aquaculture
    Publication Date: April 8, 2025

Xiaoxiao Zhong – Mechanism of Resistance – Best Researcher Award

Posted on by Infectious

Xiaoxiao Zhong - Mechanism of Resistance - Best Researcher Award

the THIRD Xiangya hospital, csu - China

AUTHOR PROFILE

ORCID

🧬 ACADEMIC FOUNDATION AND EARLY INQUIRY

Dr. Xiaoxiao Zhong began her journey in molecular biology with a keen curiosity about the Mechanism of Resistance within metabolic and glandular disorders, particularly in cancer biology. Her academic training laid the foundation for decoding the intricate cellular and molecular landscapes of diseases, especially breast cancer. The Mechanism of Resistance became a recurring theme as she explored glycosylation processes and immune microenvironments during her early research. Her initial studies bridged theory and application, combining computational and experimental approaches to understand how cancers evade immune detection. These formative years equipped her with a robust understanding of translational oncology and introduced her to the emerging significance of the tumor microenvironment. Zhong's early academic success fueled her drive to pursue multidisciplinary integration—especially in bioinformatics, transcriptomics, and high-throughput data analysis. Her pursuit to reveal the Mechanism of Resistance in disease pathways began with small but significant steps, contributing to larger discoveries that would later shape her career. Her work at Central South University provided not only a supportive academic environment but also exposure to state-of-the-art research tools and collaborative frameworks. These experiences instilled in her a lifelong mission to uncover the biological processes that define cancer behavior and their connection to the Mechanism of Resistance.

🧪 PROFESSIONAL ADVANCEMENT IN TRANSLATIONAL RESEARCH

As a Medicine Doctor at The Third Xiangya Hospital of Central South University, Dr. Xiaoxiao Zhong steadily advanced her professional career by centering her investigations around the Mechanism of Resistance in cancer therapy. Her professional endeavors are marked by an integrative approach to both clinical and laboratory settings, where she collaborates across disciplines to identify new prognostic markers and therapeutic targets. Zhong's work delves into how dysregulated metabolic pathways contribute to the Mechanism of Resistance in breast cancer. Her projects—sixteen in number—underscore her commitment to applied research with translational outcomes. She navigates between in vitro experimentation and multi-omics bioinformatics with precision, making her work both pioneering and clinically relevant. The Mechanism of Resistance is not only a research theme but a clinical puzzle she strives to solve, influencing treatment personalization and long-term patient outcomes. As a reviewer for scientific journals and a member of national research associations, she maintains active roles in advancing oncology research. Her contribution to the General Program of the National Natural Science Foundation of China reflects her recognition as a key scientific mind. Through it all, the Mechanism of Resistance remains central to her objectives, shaping the way future therapies may overcome cancer’s most persistent barriers.

🔬 RESEARCH INNOVATION AND DISCOVERY FOCUS

Dr. Xiaoxiao Zhong’s innovative research revolves around decoding the tumor microenvironment (TME) and understanding the Mechanism of Resistance that allows cancer cells to evade immune surveillance and therapeutic interventions. Her groundbreaking development of the 22-gene TME-risk signature (TMERS) has proven instrumental in advancing prognostic predictions in breast cancer. She consistently focuses on the Mechanism of Resistance embedded in glycosylation processes and immune evasion tactics, providing a dual-layered analysis that merges structural biology with immune profiling. Zhong’s research innovations also explore the role of key glycosyltransferase genes like KLRB1, whose regulatory influence she established through rigorous functional assays. Her integration of WGCNA, LASSO Cox regression, and DEG analysis demonstrates her mastery of both computational tools and biological insight. By repeatedly returning to the Mechanism of Resistance across different datasets and models, Zhong reinforces the centrality of this concept in cancer biology. Her studies do not merely describe pathways—they clarify function and mechanism. Moreover, these findings create pathways to new therapeutic interventions, especially in tumors that exhibit high resistance profiles. Zhong’s innovative strategy of combining multi-omics and experimental models ensures that her contributions remain at the frontier of cancer research, with the Mechanism of Resistance as her guiding lens.

🧠 IMPACT ON ONCOLOGY AND BIOMARKER DEVELOPMENT

The clinical and research community has benefitted immensely from Dr. Xiaoxiao Zhong’s deep analysis of the Mechanism of Resistance, especially in breast cancer. Her identification of novel prognostic biomarkers such as KLRB1 helps stratify patients more accurately, allowing clinicians to anticipate resistance-related outcomes before therapy begins. The Mechanism of Resistance in TME modeling has been at the heart of her biomarker discovery process, supporting patient-specific therapy protocols. Through gene-expression profiling, Zhong has uncovered patterns within resistant tumor populations, revealing how microenvironmental elements such as stromal and immune cells interact to foster resistance. These insights enable the classification of molecular subtypes and open avenues for personalized medicine. Her impact also extends to public repositories like the GEO database, where her models have been independently validated. Importantly, her work shines in translational relevance—where research moves from bench to bedside. She continuously examines the Mechanism of Resistance from various biological angles, ensuring a comprehensive understanding of cancer progression. This dedication not only enhances biomarker precision but reshapes diagnostic frameworks across oncology. With each study, Zhong solidifies her reputation as a forward-thinking researcher who blends innovation with applicability, driven by the persistent question: how do we decode and defeat the Mechanism of Resistance in cancer?

🏅 ACCOLADES, AFFILIATIONS, AND PROFESSIONAL RECOGNITION

Dr. Xiaoxiao Zhong’s academic and professional excellence has earned her increasing recognition both nationally and internationally. Her focus on the Mechanism of Resistance has gained the attention of peers and scientific bodies, resulting in collaborations with prestigious institutions like the National Natural Science Foundation of China. Though early in her career, she has already published seven high-impact SCI and Scopus-indexed journal articles that frequently reference the Mechanism of Resistance as a central analytical theme. Zhong’s expertise also led to an appointment as a reviewer for Case Reports in Obstetrics and Gynecology, confirming her command in evaluating complex biomedical literature. She is an active member of the Chinese Association of Pathophysiology, where she contributes insights on the Mechanism of Resistance in metabolic dysfunctions and immune escape. Her reputation is further validated by multiple citations and collaborations across various interdisciplinary projects, demonstrating the applicability of her work. While she has not yet published books or patents, the rigor and innovation in her findings promise future expansion into these domains. Through her growing network and academic contributions, Zhong continues to shape the research landscape—always with the Mechanism of Resistance as the analytical compass guiding her toward discovery and recognition.

🌍 GLOBAL RELEVANCE AND SCIENTIFIC INFLUENCE

Dr. Zhong’s research impact goes beyond national borders, as her emphasis on the Mechanism of Resistance contributes to the global scientific understanding of cancer biology. By leveraging high-throughput technologies and integrative analytics, she provides blueprints for other researchers seeking to decipher resistance pathways. Her 22-gene TMERS model has become a reference point for scientists studying tumor heterogeneity and immunological factors across populations. The international community increasingly cites her work, appreciating the way it refines the conceptualization of the Mechanism of Resistance across diverse genetic and environmental contexts. Zhong’s influence lies in her ability to connect the molecular dots between immune signaling, metabolic flux, and therapeutic failure. These connections not only elevate her research’s relevance but also inspire adaptations of her model into other cancer types. Her collaborations with global datasets and open-access platforms enhance reproducibility and transparency in science. Moreover, by showcasing how the Mechanism of Resistance is both a molecular and clinical phenomenon, she encourages a more holistic treatment strategy that transcends national health systems. Dr. Zhong’s scientific influence lies not only in her publications but also in her capacity to shape a universal language around resistance—making her a cornerstone of the new age of precision oncology.

🌱 FUTURE DIRECTIONS AND LEGACY IN BIOMEDICINE

Looking ahead, Dr. Xiaoxiao Zhong aims to deepen her exploration of the Mechanism of Resistance through next-generation sequencing, single-cell analysis, and AI-driven modeling. Her vision includes creating adaptive therapeutic strategies that consider dynamic changes within the tumor microenvironment. She aspires to develop resistance-interrupting drugs informed by biomarker-based predictions and functional genomics. Her legacy will likely be defined by her persistence in unraveling the Mechanism of Resistance and translating it into viable treatment solutions. With growing citation indices and expanding collaborations, Zhong’s influence is poised to transform clinical practices and research methodologies alike. Her efforts are gradually building a blueprint for integrating systems biology into oncology clinics. While continuing to train and mentor young researchers, she aims to establish a resistance research consortium to pool global resources in this domain. By doing so, she ensures that future scientists inherit a solid foundation of knowledge and practical frameworks for targeting the Mechanism of Resistance in multiple disease contexts. In summary, her career is not just a collection of publications—it’s an evolving legacy grounded in inquiry, collaboration, and the relentless pursuit of overcoming the Mechanism of Resistance at every biological and clinical junction.

NOTABLE PUBLICATION

  • Title: Glycosylated protein-related microenvironmental features in breast cancer are associated with patient prognosis
    Author: Xiaoxiao Zhong et al.
    Journal: Mammalian Genome
    Date: 2025-05-24

 

  • Title: PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis
    Author: Xiaoxiao Zhong (with contributor Yiqi Liu)
    Journal: American Journal of Cancer Research
    Date: 2024

 

  • Title: Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1–T2 papillary thyroid carcinoma
    Author: Xiaoxiao Zhong et al.
    Journal: Gland Surgery
    Date: 2023-11

 

  • Title: Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
    Author: Xiaoxiao Zhong et al.
    Journal: Cell Death Discovery
    Date: 2023-09-25

 

  • Title: Breast cancer combined with contralateral neck lymph node metastasis: a case report
    Author: Xiaoxiao Zhong et al.
    Journal: Diagnostic Pathology
    Date: 2022-12

Bidyut Matubber – Antibiotic – Best Researcher Award

Posted on by Infectious

Bidyut Matubber - Antibiotic - Best Researcher Award

Khulna Agricultural University - Bangladesh

AUTHOR PROFILE

GOOGLE SCHOLAR 

EARLY ACADEMIC PURSUITS 🎓

Dr. Bidyut Matubber’s academic foundation is deeply rooted in veterinary public health and food hygiene. He completed his Doctor of Veterinary Medicine (DVM) in 2017 from Patuakhali Science and Technology University, securing a commendable CGPA of 3.74. Demonstrating his passion for advanced learning, he pursued a Master of Veterinary Public Health and Food Hygiene with a major in Antimicrobial Resistance, graduating with a perfect CGPA of 4.00 in 2019. These formative years reflect a consistent commitment to academic excellence and laid the groundwork for his specialization in food microbiology. During his master's tenure, Dr. Matubber actively participated in hands-on research activities, including antibiogram studies and chromatographic analysis. His academic environment exposed him to a multidisciplinary research setting, fostering a deeper understanding of microbiological threats in food systems. This exposure played a pivotal role in shaping his career and interest in public health. With a solid base in microbiology, statistics, and biosafety, he was well-prepared to address complex public health concerns, particularly those linked to antimicrobial resistance. His early academic journey was not just a pursuit of degrees but a strategic investment toward a research-intensive future in veterinary science and food safety, setting the stage for his impactful contributions.

PROFESSIONAL ENDEAVORS 🧪

Dr. Bidyut Matubber’s professional career commenced with a focused approach toward academia and applied research. Since November 2020, he has been serving as an Assistant Professor in the Department of Microbiology and Public Health at Khulna Agricultural University. In this role, he spearheads research on antimicrobial resistance and chemical residues in food items such as meat and milk. His work extends to critical extension activities, strengthening collaboration between universities, research institutions, and livestock farmers. His contributions aim to bridge the gap between scientific discoveries and practical applications in food safety. Prior to this, Dr. Matubber held the position of Master Research Fellow at his alma mater, where he honed his research skills in statistical software such as SPSS and R. He has also undergone extensive training in laboratory biosafety, surveillance, foot-and-mouth disease investigation, and herd production management. These multidimensional experiences enrich his capacity as both a researcher and educator. Dr. Matubber is not confined to the laboratory; his outreach and on-ground surveys enable him to assess real-world challenges faced by food handlers and animal health workers. His professional endeavors reflect a dynamic balance between rigorous research and meaningful community engagement, ensuring relevance and impact in every project he undertakes.

RESEARCH CONTRIBUTIONS AND FOCUS 🔬

Dr. Bidyut Matubber’s research trajectory is anchored in the critical domains of antimicrobial resistance (AMR), food microbiology, and public health. His work scrutinizes the presence of antibiotic resistance and chemical residues in livestock products — particularly meat and milk — in southern Bangladesh. His findings have been published in several reputable national and international journals, reinforcing his reputation as a dedicated scientific voice in the food safety sector. Notably, his recent studies explore the microbial contamination of street foods and the prevalence of multidrug-resistant pathogens in urban meat markets. These investigations have significant implications for public health, especially in developing countries grappling with poor food hygiene infrastructure. Dr. Matubber is also a contributing author in interdisciplinary topics, ranging from student mental health during online learning to reproductive issues in livestock. His collaborative research style has earned him co-authorship with international scholars and local experts, highlighting the diverse scope of his academic inquiries. Moreover, his work on biofilm resistance in farm industries and the evaluation of organic acid alternatives to antibiotic growth promoters reflect his forward-thinking approach. Altogether, his research contributions aim not just to describe problems but to offer actionable, evidence-based solutions in public health microbiology.

AWARDS AND RECOGNITION 🏆

Dr. Bidyut Matubber’s exemplary contributions to veterinary public health and food microbiology have been widely acknowledged through prestigious accolades. He was awarded the NST Research Fellowship (2019) by the Ministry of Science and Technology, Bangladesh — a competitive grant that recognized his potential in the field of antimicrobial resistance. In 2020, he won the Best Poster Presentation Award at the 3rd Annual Scientific Conference organized by the Coastal Vet Society of Bangladesh, showcasing his ability to communicate research effectively to scientific audiences. Further acknowledging his innovation and commitment, the Ministry of Science and Technology honored him with the Technology Invention, Research, and Development Project (R&D) grants in both 2021 and 2022. Perhaps most significantly, he received the Best Researcher Award (2022) from the Khulna Agricultural University Teacher’s Association for his outstanding scholarly accomplishments. These accolades are not just ceremonial; they are powerful affirmations of Dr. Matubber’s enduring influence in microbiology and public health research. They reflect his relentless pursuit of scientific excellence, impactful community engagement, and forward-looking research that addresses urgent food safety challenges in Bangladesh. Each award underlines a milestone in his evolving career, cementing his place as a key thought leader in his domain.

IMPACT AND INFLUENCE 🌍

Dr. Matubber's research has far-reaching implications for public health policy and food safety in Bangladesh. His work on antimicrobial resistance in meat and milk serves as a wake-up call for food safety regulators and veterinary policymakers. By highlighting the presence of drug-resistant bacteria in widely consumed animal products, his studies provide a critical evidence base for shaping food inspection protocols and public awareness campaigns. Beyond his published findings, Dr. Matubber plays a pivotal role in academic and field-level training, educating young researchers and practitioners about biosafety, food hygiene, and AMR surveillance. His influence also extends into interdisciplinary domains, as seen in his co-authored work on student anxiety during e-learning and reproductive health in livestock. Dr. Matubber's ability to synthesize data into policy-relevant recommendations amplifies his impact beyond academia. As a faculty member, he actively mentors future scientists and contributes to the university's knowledge-sharing platforms. His integrated approach — combining lab research, fieldwork, teaching, and publication — creates a ripple effect of influence across public health, education, and rural livelihoods. Through conferences, training programs, and collaborative networks, Dr. Matubber continues to shape not only scientific discourse but also the operational realities of food safety and veterinary health in Bangladesh.

LEGACY AND FUTURE CONTRIBUTIONS 🔭

Dr. Bidyut Matubber’s academic journey and professional milestones lay the foundation for a legacy marked by scientific integrity, community relevance, and transformative impact. Looking ahead, he is poised to expand his research into broader themes like the environmental reservoirs of antimicrobial resistance, molecular epidemiology, and climate-linked zoonotic diseases. His ongoing projects involving the contamination levels in street food and multidrug-resistant pathogens in meats are likely to evolve into larger surveillance frameworks with regional or national scope. Moreover, Dr. Matubber envisions integrating genomic tools and AI-driven analytics into his research to better understand resistance mechanisms. As a faculty member, he aims to establish a specialized research hub within Khulna Agricultural University that focuses on foodborne pathogens and antibiotic resistance. His long-term goals include mentoring doctoral candidates and fostering international research collaborations, particularly in South Asia and Southeast Asia. With his background in both laboratory and field-based research, Dr. Matubber is ideally positioned to contribute to global initiatives like the WHO's One Health framework. His legacy will not only be defined by his publications or awards, but by the structural improvements he brings to food safety systems, academic training, and public health policies in Bangladesh and beyond.

SUMMARY OF ACHIEVEMENTS 🧾

Dr. Bidyut Matubber is a dynamic academic, microbiologist, and public health researcher based at Khulna Agricultural University. With over five years of expertise in food microbiology and antimicrobial resistance, his work has led to impactful research on contamination in meat, milk, and street foods across southern Bangladesh. He has co-authored numerous papers in reputed journals, participated in national training programs, and successfully acquired competitive grants. His professional tenure includes key roles as an Assistant Professor and Master Research Fellow, underscoring a consistent trajectory of growth. Recognized for both scientific innovation and practical relevance, he has received prestigious awards, including the NST Research Fellowship and the Best Researcher Award by his university. His research has informed public policy and raised awareness about food safety issues in underserved communities. By combining rigorous lab work, strategic field outreach, and teaching excellence, Dr. Matubber exemplifies a researcher whose work transcends academia to affect real-world change. His story is one of perseverance, interdisciplinary collaboration, and a passionate commitment to improving health outcomes through science.

NOTABLE PUBLICATION

  • Title: Anxiety and its determinants among undergraduate students during E-learning in Bangladesh amid COVID-19
    Authors: MN Hoque, A Hannan, S Imran, MA Alam, B Matubber, SM Saha
    Journal: Journal of Affective Disorders Reports, Volume 6, Article 100241, 2021

 

  • Title: Factors associated with food safety knowledge and practices among meat handlers in Bangladesh: a cross-sectional study
    Authors: MH Al Banna, TR Disu, S Kundu, BO Ahinkorah, K Brazendale, AA Seidu, ...
    Journal: Environmental Health and Preventive Medicine, Volume 26, Article 84, 2021

 

  • Title: Pernicious attitude of microbial biofilms in agri-farm industries: Acquisitions and challenges of existing antibiofilm approaches
    Authors: SH Toushik, A Roy, M Alam, UH Rahman, NK Nath, S Nahar, B Matubber, ...
    Journal: Microorganisms, Volume 10, Issue 12, Article 2348, 2022

 

  • Title: Evaluation of different parameters in relation to repeat breeding of cows at the coastal areas of Bangladesh
    Authors: B Matubber, AK Paul, S Das
    Journal: Research in Agriculture Livestock and Fisheries, Volume 5, Issue 1, Pages 49–55, 2018

 

  • Title: Antibiotic resistance and residue in chicken, cattle, buffalo and goat meats in different southern districts of Bangladesh
    Authors: B Matubber, FI Rume, MEH Kayesh, MM Rahman, MR Amin, MA Asgar, ...
    Journal: Asian-Australasian Journal of Food Safety and Security, Volume 5, Issue 1, Pages 19–26, 2021

Yang Cheng – Malaria – Best Researcher Award

Posted on by Infectious

Yang Cheng - Malaria - Best Researcher Award

Institute for Prevention and Control of Tropical Diseases and Chronic Diseases, Hainan Provincial Center for Disease Control and Prevention - China

AUTHOR PROFILE 

SCOPUS

EARLY ACADEMIC ROOTS 🎓

Dr. Yang Cheng’s academic journey began with a profound interest in medicine and parasitology. Born in May 1986, he pursued his Bachelor’s degree in Clinical Medicine from Bengbu Medical College, China, graduating in 2009. Motivated by the complex biology of parasites and their interactions with human hosts, he pursued a Ph.D. in Human Parasitology at Kangwon National University, South Korea, and obtained his doctorate in 2014. His time abroad broadened his exposure to international research perspectives, laying the groundwork for a robust academic career. Post-Ph.D., Dr. Cheng further honed his expertise through a postdoctoral research position at the prestigious NIH-NIAID (USA) from 2014 to 2016. This phase was instrumental in sharpening his scientific acumen, allowing him to work with globally respected researchers in immunology and infectious diseases. His diverse academic background—spanning Asia and the United States—prepared him to tackle global parasitic diseases with a cross-disciplinary approach. With each academic milestone, Dr. Cheng cultivated a deepening focus on malaria infection and host immune response, eventually positioning himself as a key thought leader in tropical disease research.

PROFESSIONAL JOURNEY & LEADERSHIP 🧑‍🔬

Dr. Cheng’s professional trajectory is distinguished by leadership roles and impactful research. In 2016, he became an Associate Professor at Jiangnan University, Wuxi, China, where he also assumed the role of Chief Leader of the Pathogenic Infection and Immunity Laboratory. His leadership extends to Hainan, where he directs the Institute for Prevention and Control of Tropical Diseases and Chronic Diseases at the Hainan Provincial Center for Disease Control and Prevention. His dual appointments reflect his commitment to both academic advancement and public health application. Beyond titles, Dr. Cheng has led numerous high-profile research initiatives. He currently heads multiple funded projects, including grants from the Natural Science Foundation of China, Jiangsu Province, the Bill & Melinda Gates Foundation, and Central Universities' Fundamental Research Funds. His ability to manage interdisciplinary research, mentor junior scientists, and lead disease prevention programs solidifies his reputation as a leader in the field. Balancing lab discovery with field implementation, Dr. Cheng bridges research with policy and practice, especially in endemic regions.

RESEARCH EXCELLENCE IN MALARIA & IMMUNOLOGY 🧬

At the heart of Dr. Cheng’s career lies his passion for understanding malaria pathogenesis and immune response. His work focuses on four interconnected areas: the invasion mechanisms of Plasmodium, the host’s immune response and immune evasion, screening of malaria vaccine candidates, and public prevention of parasitic diseases. Through a combination of molecular biology, immunology, and epidemiology, he has advanced knowledge in how Plasmodium interacts with host cells and evades immune detection. His research has resulted in over 20 SCI-indexed publications as first or corresponding author, underscoring both volume and scientific rigor. Notably, his recent work has revealed important roles for proteins such as PvMSP1P-19, PvTRAg23, and GAMA in malaria pathogenesis and immune modulation. By identifying targets for potential vaccines and therapeutics, Dr. Cheng's contributions support global efforts to eradicate malaria. His innovative experiments, often involving collaborative research teams, have been well-recognized in journals such as The Journal of Biological Chemistry, Frontiers in Immunology, and Infection and Immunity. Dr. Cheng's research doesn’t just decode molecular interactions—it creates practical pathways for disease control strategies.

GLOBAL COLLABORATIONS & SCIENTIFIC IMPACT 🌏

Dr. Cheng has actively collaborated across borders, enhancing the global footprint of his research. His postdoctoral tenure at the NIH-NIAID fostered early international experience, but his collaborations have since extended through participation in multi-national conferences, international grants, and co-authored studies. Notably, his research supported by the Bill & Melinda Gates Foundation highlights global trust in his work’s applicability to malaria control. Additionally, his papers often include international co-authors from diverse regions such as Africa, Korea, and Southeast Asia, indicating the geographic relevance and appeal of his findings. His participation in One Health discussions and COVID-19 response analysis showcases his versatility and responsiveness to emerging global threats. Dr. Cheng’s research on the genetic diversity and immunogenicity of Plasmodium species imported from Africa to China speaks to his role in transcontinental disease tracking. These partnerships have enabled knowledge transfer and capacity building in endemic regions, strengthening public health infrastructures. By working with global teams, Dr. Cheng has become a conduit for scientific exchange, policy dialogue, and technological innovation in tropical medicine.

AWARDS AND DISTINCTIONS 🏅

Recognition of Dr. Cheng’s outstanding research and leadership is reflected in the accolades he has received. In 2014, he was honored with the PhD of Excellence by Kangwon National University, a testament to his exceptional doctoral work. Six years later, in 2020, he was named Honor Young Scientist Scholar at Jiangnan University, affirming his continued contribution to academic research and student mentorship. He also received the Science and Technology Award from the China General Chamber of Commerce the same year, which acknowledged his applied scientific efforts and innovation in health-related research. These awards highlight his dual strengths: theoretical rigor and practical impact. Dr. Cheng’s ability to transform complex research into public health strategies, particularly in parasitic disease control, has been critical in earning these distinctions. His awards not only validate his contributions but also set a benchmark for emerging researchers under his mentorship. As a role model and thought leader, he has cultivated a research environment focused on excellence, integrity, and social relevance.

SCIENTIFIC CONTRIBUTIONS & PUBLICATIONS 📚

Dr. Cheng’s publication record is both prolific and impactful, with over 20 SCI-indexed articles that span molecular parasitology, immunology, and public health. His 2024 study in The Journal of Biological Chemistry revealed how PvMSP1P-19 binds with membrane proteins band3 and CD71, advancing our understanding of Plasmodium vivax reticulocyte invasion. In another 2024 paper in Infection and Immunity, he examined the interaction between PySRA and macrophage receptors, shedding light on how malaria parasites manipulate host immune responses. His interdisciplinary approach also led to studies on PvTRAg23’s effect on spleen fibroblasts, COVID-19 epidemiology, and immune signaling pathways like cGAS-STING. His work demonstrates a continuous thread of innovation—from bench research to field-level application. Each publication not only contributes to scientific discourse but also serves as a building block for vaccine development, diagnostic tool refinement, and epidemiological forecasting. His research frequently bridges basic science and translational outcomes, with far-reaching implications for disease surveillance and health policy.

LEGACY AND FUTURE ASPIRATIONS 🔮

Dr. Cheng stands at the forefront of infectious disease research with a legacy defined by innovation, leadership, and global vision. His future trajectory promises continued advancement in malaria vaccine development, immune evasion mechanisms, and public health interventions. As Director of a key disease control institute and a research lab leader, he is well-positioned to influence both academic inquiry and practical policy. He envisions building a multidisciplinary center for tropical diseases, incorporating genomics, immunology, and big data analytics to combat emerging parasitic threats. Moreover, he remains committed to mentoring the next generation of scientists, creating a ripple effect of knowledge and skill development across borders. With growing international collaborations, sustained publication momentum, and a strong foundation in both theory and practice, Dr. Cheng’s legacy is still in the making—one that aligns with global health goals and scientific excellence.

NOTABLE PUBLICATION

  • Title: Proteomic profiling of spleen in rat infected with Clonorchis sinensis using liquid chromatography tandem mass spectrometry analysis
    Authors: S. Han, Su; J. Wan, Jie; X. Zhang, Xiaoli; J. Wu, Jianlin; R. Chen, Rui
    Journal: Acta Tropica
  • Title: MicroRNAs in opisthorchiids and their definitive hosts: Current Status and Perspectives
    Authors: X. Li, Xiang; J. Ding, Jian; X. Zhang, Xiaoli; J. Cao, Jianping; S. Han, Su
    Journal: [Journal not specified] (Full text link is disabled, and journal name not shown)
  • Title: Plasmodium vivax tryptophan-rich antigen reduces type I collagen secretion via the NF-κBp65 pathway in splenic fibroblasts
    Authors: W. Kong, Weizhong; H. Zhang, Hangye; Y. Sun, Yifan; S. Han, Su; Y. Cheng, Yang
    Journal: Parasites and Vectors
  • Title: ASIC1 promotes migration and invasion of hepatocellular carcinoma via the PRKACA/AP-1 signaling pathway
    Authors: Y. Liu, Youyi; B. Wang, Boshi; Y. Cheng, Yang; Y. He, Youzhao; C. Jin, Cheng
    Journal: Carcinogenesis
  • Title: The Plasmodium vivax MSP1P-19 is involved in binding of reticulocytes through interactions with the membrane proteins band3 and CD71
    Authors: S. Zuo, Shenghuan; J. Lu, Jiachen; Y. Sun, Yifan; E. Han, Eun-Taek; Y. Cheng, Yang
    Journal: Journal of Biological Chemistry

Jennifer Le – Childhood Infectious Diseases – Best Researcher Award

Posted on by Infectious

Jennifer Le - Childhood Infectious Diseases - Best Researcher Award

University of California, San Diego Skaggs school of Pharmacy - United States

AUTHOR PROFILE 

GOOGLE SCHOLAR

FOUNDATION OF EXCELLENCE 🧬

Dr. Jennifer Le’s path toward a distinguished academic career began with a Bachelor of Science in Biology from UCLA, followed by a Doctor of Pharmacy from UCSF. Her drive to specialize further led her to a pharmacy residency at Long Beach Memorial and an advanced research degree from UC San Diego. From these solid academic foundations, Dr. Le built a dynamic career in clinical pharmacology. Her early fascination with the intersection of biology and therapeutics evolved into a passion for pediatric infectious diseases, pharmacokinetics, and antimicrobial stewardship. Her advanced training was pivotal in shaping her translational research capabilities and patient-centered focus. Her ongoing commitment to education was further emphasized by her attainment of numerous certifications in areas like pharmacotherapy, infectious diseases, and clinical research. These qualifications provided her with the breadth and depth required for a role that straddles research, clinical care, and academia. Throughout, Dr. Le has maintained active pharmacist licensure and research certifications, continuously expanding her capabilities in both patient safety and innovative pharmacological approaches. This comprehensive training laid the groundwork for a lifelong contribution to science and medicine, deeply rooted in rigorous academic preparation and an enduring dedication to improving pediatric and infectious disease outcomes.

LEADERSHIP IN CLINICAL PHARMACY 🧪

As a Professor of Clinical Pharmacy at the University of California San Diego, Dr. Jennifer Le exemplifies visionary leadership in education and patient care. Her role as Director of Experiential Education and Chair of the Committee on International Pharmacy Education and Research reflects her dedication to shaping future pharmacists through hands-on, globally-informed education. Her earlier posts at Western University and extensive tenure at MemorialCare Health System reveal her long-standing involvement in bridging academic knowledge with clinical applications. Dr. Le has developed and coordinated multiple therapeutic courses, integrating complex subjects such as pharmacokinetics, infectious diseases, and pediatric pharmacotherapy. She has served as both preceptor and mentor to over 300 students, residents, and early-career faculty, highlighting her pivotal role in guiding the next generation of clinicians and researchers. Beyond teaching, she has served on numerous university committees—ranging from curriculum development to faculty mentorship—demonstrating her multidimensional leadership. Her thoughtful curriculum designs and practical preceptorships have directly contributed to enhanced clinical skills among students. Her long-standing influence in shaping pharmacy education, particularly in infectious disease and pediatric care, has garnered admiration and recognition across academic institutions and professional circles. Through these roles, Dr. Le continues to redefine clinical pharmacy education with academic rigor and compassionate mentorship.

INNOVATION IN PEDIATRIC PHARMACOLOGY 👶

Dr. Le's research portfolio is a testament to her pioneering work in pediatric clinical pharmacology. She has led and collaborated on numerous investigator-initiated projects, including NIH-funded studies totaling over $11.8 million. Her research has primarily focused on optimizing antibiotic dosing in neonates and children through pharmacokinetic/pharmacodynamic modeling. From exploring vancomycin and aminoglycoside exposure in pediatric patients to identifying dosing requirements in neonates with sepsis, Dr. Le has delivered actionable insights that are transforming pediatric care. Her work within the Pediatric Trials Network and contributions to model-informed precision dosing highlight her commitment to tailoring therapies to vulnerable populations. This patient-centered research has been instrumental in improving therapeutic outcomes and minimizing drug toxicity. She has also authored multiple national consensus guidelines on antimicrobial use and vancomycin monitoring in pediatric care, reflecting her influence on best practices across institutions. With more than 200 publications to her name, Dr. Le has made impactful contributions to journals specializing in pharmacotherapy, infectious diseases, and pediatric medicine. Her work continues to bridge gaps between bench research and bedside care, using data-driven models and clinical acumen to enhance drug safety and efficacy in pediatric populations globally.

ADVOCACY FOR MEDICATION SAFETY & GUIDELINES 📋

A leader in pharmacovigilance, Dr. Jennifer Le has consistently advocated for safer medication practices, especially in pediatric and critical care settings. Her seminal contributions to the national vancomycin guidelines, developed alongside the Infectious Diseases Society of America and other prestigious bodies, have transformed monitoring protocols across U.S. hospitals. Dr. Le’s expertise in therapeutic drug monitoring and pharmacokinetics has led to paradigm-shifting approaches in antimicrobial stewardship, emphasizing AUC-based dosing over traditional methods to better predict efficacy and prevent toxicity. Her work has not only influenced hospital protocols but also shaped regulatory guidance. Dr. Le has served as a consultant for the FDA’s Antimicrobial Drugs Advisory Committee and international drug monitoring agencies, demonstrating her credibility and influence in public health. She’s also helped develop tools for Bayesian estimation and has advised on the integration of pharmacokinetics in electronic health records for better clinical decision-making. Beyond her research and consulting, she has led initiatives in minimizing medication errors, especially in neonates and immunocompromised children, populations often overlooked in clinical trials. Her efforts ensure that safety remains central to innovation in pharmacotherapy, making her a steadfast advocate for vulnerable patients and a driving force behind more intelligent and equitable healthcare delivery.

GLOBAL IMPACT THROUGH EDUCATION 🌍

Dr. Le’s influence extends far beyond U.S. borders through her dedication to international pharmacy education and research collaboration. As Chair of the Committee on International Pharmacy Education and Research at UCSD, she has spearheaded efforts to globalize pharmacy training, facilitating faculty exchange, curriculum design, and policy development with institutions across Asia and the Middle East. Her work with Hanoi University of Pharmacy and hospitals in Vietnam illustrates her commitment to strengthening global healthcare systems through knowledge exchange and capacity building. She has delivered keynote lectures at international pediatric antimicrobial stewardship conferences and conducted training workshops in countries like Taiwan and Vietnam, focusing on therapeutic drug monitoring and antibiotic dosing in children. These efforts have directly contributed to the implementation of advanced pharmacological practices in resource-limited settings. Dr. Le also serves on advisory panels for global journals and international pharmacotherapy initiatives, ensuring that global voices are heard in scientific discourse. Her mentorship of international pharmacists and researchers has fostered enduring professional networks. Through these actions, Dr. Le embodies the spirit of global health equity—ensuring that the latest advancements in pediatric pharmacology and drug safety are accessible and applicable around the world.

DISTINCTIONS & PROFESSIONAL HONORS 🏅

Throughout her career, Dr. Le has earned widespread acclaim and numerous accolades that reflect both her scientific excellence and leadership. She is a Fellow of the Infectious Diseases Society of America (FIDSA), American College of Clinical Pharmacy (FCCP), and California Society of Health-Systems Pharmacists (FCSHP)—a rare trifecta underscoring her multidisciplinary expertise. She was the recipient of the Sternfels Prize for Drug Safety Innovation and was honored in Marquis Who’s Who in America for her contributions to academia and public health. Her mentorship excellence was recognized with UCSD’s Outstanding Mentor Award, and she’s frequently invited to serve on expert panels, including those for NIH, AHRQ, PCORI, and the National Science Foundation. Dr. Le has also been a sought-after consultant for clinical trial design and regulatory pharmacology with the FDA and international agencies. These distinctions not only recognize her personal achievements but also amplify her role in shaping the future of pharmacological sciences. Her awards reflect years of innovative research, effective mentorship, and unwavering dedication to public service. Dr. Le’s reputation is built not only on academic merit but also on a deep sense of professional responsibility to foster the next generation of healthcare leaders.

LEGACY OF MENTORSHIP & FUTURE TRAJECTORY 🌱

As a seasoned academic and healthcare leader, Dr. Jennifer Le continues to nurture the future of pharmacy through robust mentorship and visionary research. She has mentored more than 300 individuals, from pharmacy residents to early-career faculty, instilling in them the principles of scientific inquiry and compassionate care. Her mentorship programs at UCSD have fostered diverse talent pipelines and inspired many to pursue academic and clinical excellence. Dr. Le is currently leading initiatives in model-informed precision dosing and developing training modules for underrepresented groups in clinical research. Her trajectory suggests a continued expansion of global partnerships, particularly in resource-limited countries, to elevate the standard of pediatric care. With a keen interest in bridging technology and therapeutics, she is expected to play a major role in integrating AI-driven pharmacokinetics into routine clinical practice. As regulatory agencies increasingly look to expert clinicians for guidance, Dr. Le’s influence on national and international policy will only grow. Her enduring legacy lies in her capacity to translate science into practice, inspire young scientists, and build institutions that embody both rigor and equity. Through her multifaceted contributions, she is shaping not just the future of pharmacy—but the future of health.

NOTABLE PUBLICATION

  • Title: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review
    Authors: MJ Rybak, J Le, TP Lodise, DP Levine, JS Bradley, C Liu, BA Mueller, et al.
    Journal: American Journal of Health-System Pharmacy

 

  • Title: Improved vancomycin dosing in children using area under the curve exposure
    Authors: J Le, JS Bradley, W Murray, GL Romanowski, TT Tran, N Nguyen, S Cho, et al.
    Journal: The Pediatric Infectious Disease Journal

 

  • Title: Urinary tract infections during pregnancy
    Authors: J Le, GG Briggs, A McKeown, G Bustillo
    Journal: Annals of Pharmacotherapy

 

  • Title: Adverse drug reactions among children over a 10-year period
    Authors: J Le, T Nguyen, AV Law, J Hodding
    Journal: Pediatrics

 

  • Title: Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children
    Authors: S McKamy, E Hernandez, M Jahng, T Moriwaki, A Deveikis, J Le
    Journal: The Journal of Pediatrics

Zishan Gao – Pain – Best Researcher Award

Posted on by Infectious

Zishan Gao - Pain - Best Researcher Award

Epidemiology institute - Germany

AUTHOR PROFILE 

ORCID

EARLY ACADEMIC PURSUITS 🎓

Dr. Zishan Gao, formerly known as Jun Gao until 2013, laid the foundation of his scholarly journey at the Chengdu University of Traditional Chinese Medicine. He earned his B.S., M.S., and Ph.D. in Acupuncture and Moxibustion, under the mentorship of eminent figures such as Prof. Xuguang Liu and Prof. Fanrong Liang. During this formative academic period, he developed a keen interest in Traditional Chinese Medicine (TCM), integrating ancient healing wisdom with modern analytical methods. His dissertation and subsequent research underscored a rigorous, evidence-based approach to acupuncture's physiological effects, particularly using metabolomics and bioinformatics. Driven by a curiosity to bridge holistic traditions with scientific inquiry, Dr. Gao sought out global perspectives, receiving specialized training from leading institutions such as McMaster University, EMBL, and Helmholtz Munich. These diverse international exposures enriched his methodological acumen in genomic annotation, high-dimensional data statistics, and comparative effectiveness research. His academic trajectory reflects not only technical mastery but also a relentless pursuit of understanding complex biological mechanisms underlying acupuncture and moxibustion. By building this robust educational foundation, Dr. Gao positioned himself as a bridge between traditional Eastern practices and modern biomedical research, embodying a truly translational and interdisciplinary mindset from the onset of his career.

PROFESSIONAL ENDEAVORS 🧑‍🔬

Dr. Zishan Gao currently serves as an Associate Professor at Nanjing University of Chinese Medicine, a role he has held since 2018. His professional journey has also seen notable international milestones, including a fellowship at the Research Unit of Molecular Epidemiology in Munich and a Marie Curie Fellowship at the Italian Acupuncture Association. These experiences not only expanded his academic influence but also allowed him to foster global collaborations in acupuncture, genetic epidemiology, and personalized medicine. At Nanjing University, Dr. Gao’s leadership is evident in both teaching and research capacities. He has overseen multiple research grants from prestigious bodies like the National Natural Science Foundation of China and has also designed pragmatic clinical trials that integrate acupuncture with modern therapeutic approaches. His responsibilities span from study design to data interpretation, animal experimentation, and molecular biology techniques such as PCR, Western blotting, and immunohistochemistry. Moreover, his role as a co-supervisor to numerous M.S. students highlights his commitment to mentoring the next generation of integrative medicine researchers. His multifaceted professional engagements reflect a rare blend of scientific rigor and traditional insight, making Dr. Gao a pivotal figure in modernizing Chinese Medicine through empirical validation and interdisciplinary synthesis.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

At the heart of Dr. Zishan Gao’s research lies a deep commitment to exploring the mechanisms of Traditional Chinese Medicine using modern scientific methodologies. His pioneering work has primarily focused on the therapeutic mechanisms of acupuncture and moxibustion, especially in treating complex conditions like rheumatoid arthritis and migraine. Utilizing metabolomics, bioinformatics, and genomics, Dr. Gao has conducted groundbreaking studies demonstrating how acupuncture influences metabolic pathways, gene expression, and immune regulation. Notably, his investigations into the NLRP3-IL-1β pathway and lipid metabolism have shed light on how mitochondrial function and immune activation intersect in chronic inflammatory diseases. His ability to merge metabolomic data with clinical outcomes using sophisticated machine learning techniques—like OPLS-DA and Cox regression—has helped quantify and validate the specificity of acupuncture points. Furthermore, he contributed significantly to the GIANT and GCLC GWAS consortiums, analyzing genomic data from thousands of participants to identify genetic markers related to lipids and height. Dr. Gao’s integrative research focus not only reinforces the scientific credibility of acupuncture but also extends its application to personalized medicine. His comprehensive approach—ranging from animal models to large-scale cohort analysis—positions him at the forefront of translational research in integrative health sciences.

ACCOLADES AND RECOGNITION 🏅

Dr. Zishan Gao’s dedication and innovative research have earned him numerous prestigious accolades, underscoring his influence in both Chinese and global scientific communities. A standout recognition includes his selection as a Marie Curie Fellow under the European Union’s Seventh Framework Program, a mark of excellence awarded to leading researchers across Europe. Furthermore, his contributions to the academic and scientific advancement of Jiangsu Province were acknowledged through the “333 Talents” Program (2022–2025), a provincial-level honor given to exceptional scholars driving research and innovation. Earlier in his career, Dr. Gao was awarded the Annual Doctorate Grant at Chengdu University and received accolades in national science competitions, illustrating early promise in research. He has also played a vital role in the academic review community, serving as a reviewer for several prominent journals including BMJ Open, Frontiers in Neuroscience, and Journal of Traditional Chinese Medicine. As a grant reviewer for the National Natural Science Foundation of China across multiple years, his expertise is widely respected. These honors not only reflect his technical competence but also his thought leadership in advancing evidence-based Traditional Chinese Medicine. Through sustained excellence, Dr. Gao has built a legacy of achievement that transcends national and disciplinary boundaries.

IMPACT AND INFLUENCE 🌍

Dr. Zishan Gao’s work has significantly influenced the modernization and global acceptance of acupuncture and Traditional Chinese Medicine. His research has introduced a rigorous scientific framework to evaluate the efficacy and mechanisms of traditional therapies. Through numerous national and international collaborations, he has helped build bridges between Eastern healing philosophies and Western scientific paradigms. His studies on metabolic and genomic changes induced by acupuncture have advanced the understanding of individualized responses to treatment, aligning with the global push toward precision medicine. By contributing to major GWAS consortia and engaging in translational research, Dr. Gao has extended the relevance of TCM into mainstream biomedical discourse. His publications in high-impact journals like Nature and BMJ have given acupuncture research international visibility, promoting its integration into complementary and integrative medicine practices worldwide. Furthermore, his leadership in major clinical trials and comparative effectiveness research has influenced policy-level discussions on the value of integrative treatments. Dr. Gao’s influence is felt not only in academic circles but also in clinical settings, where his findings inform best practices. His work exemplifies how traditional knowledge can be revitalized through scientific validation, setting a precedent for future cross-disciplinary medical research.

LEGACY AND FUTURE CONTRIBUTIONS 📚

As he continues to lead cutting-edge research in integrative medicine, Dr. Zishan Gao is poised to shape the next chapter of acupuncture and moxibustion studies with a translational and global vision. His career is defined by a relentless quest to bridge tradition with innovation. Looking ahead, his legacy will be anchored in three pillars: scientific rigor, interdisciplinary collaboration, and mentorship. Dr. Gao’s commitment to training future scholars ensures a pipeline of researchers capable of advancing evidence-based Traditional Chinese Medicine. His involvement in genetic epidemiology, multi-omics analysis, and data science also signals a forward-looking approach that resonates with contemporary biomedical priorities. Moreover, his active role in international consortia and multicenter trials highlights his intention to position acupuncture as a scientifically robust and universally accepted therapeutic modality. Through continued publications, student mentorship, and global partnerships, Dr. Gao aims to dismantle the barriers between ancient medical traditions and modern clinical standards. His work will likely catalyze the global transformation of TCM from anecdotal practice to empirically grounded healthcare, thereby leaving an enduring imprint on the world of integrative health sciences.

NOTABLE PUBLICATION

  • Title: Metabolomics Reveals Reasons for the Efficacy of Acupuncture in Migraine Patients: The Role of Anaerobic Glycolysis and Mitochondrial Citrate in Migraine Relief
    Authors: Zishan Gao, Xianzhong Yan, Rui Wang-Sattler, Marcela Covic, Guang Yu, Feifei Ge, Jia Lin, Qin Chen, Juan Liu, Sapna Sharma et al.
    Journal: Phenomics
    Publication Date: 2025-05-04

 

  • Title: Metabolomics Reveals Reasons for the Efficacy of Acupuncture in Migraine Patients: The Role of Anaerobic Glycolysis and Mitochondrial Citrate in Migraine Relief (Preprint)
    Authors: Zishan Gao, Xianzhong Yan, Rui Wang-Sattler, Marcela Covic, Guang Yu, Feifei Ge, Jia Lin, Qin Chen, Juan Liu, Sapna Sharma et al.
    Journal: medRxiv (Preprint)
    Publication Date: 2023-10-15

 

  • Title: Implicating Genes, Pleiotropy, and Sexual Dimorphism at Blood Lipid Loci Through Multi-Ancestry Meta-Analysis
    Authors: Stavroula Kanoni, Sarah E. Graham, Yuxuan Wang, Ida Surakka, Shweta Ramdas, Xiang Zhu, Shoa L. Clarke, Konain Fatima Bhatti, Sailaja Vedantam, Thomas W. Winkler et al.
    Journal: Genome Biology
    Publication Date: 2022-12-27

 

  • Title: A Saturated Map of Common Genetic Variants Associated with Human Height
    Authors: Loic Yengo, Sailaja Vedantam, Eirini Marouli, Julia Sidorenko, Eric Bartell, Saori Sakaue, Marielisa Graff, Anders U. Eliasen, Yunxuan Jiang, Sridharan Raghavan et al.
    Journal: Nature
    Publication Date: 2022-10-27

 

  • Title: A Multi-Layer Functional Genomic Analysis to Understand Noncoding Genetic Variation in Lipids
    Authors: Shweta Ramdas, Jonathan Judd, Sarah E. Graham, Stavroula Kanoni, Yuxuan Wang, Ida Surakka, Brandon Wenz, Shoa L. Clarke, Alessandra Chesi, Andrew Wells et al.
    Journal: The American Journal of Human Genetics
    Publication Date: 2022-08

Gouvidé Jean GBAGUIDI – Malaria – Best Researcher Award

Posted on by Infectious

Gouvidé Jean GBAGUIDI - Malaria - Best Researcher Award

West African Science Service on Climate change and Adapted Land Use(WASCAL) - Benin

 

AUTHOR PROFILE

ORCID

🌍 EARLY ACADEMIC ROOTS AND FORMATIVE EDUCATION

Gouvidé Jean Gbaguidi was born on March 8, 1989, in the Republic of Benin. His early academic pursuits reflect a steady and determined climb through the sciences. Beginning with a Scientific Baccalaureate in 2011, he progressed to earn a Bachelor’s degree in Chemistry-Biology-Geology, followed by a Master of Science in Natural Sciences with a focus on Biology in 2016. Not one to rest on accomplishments, he pursued a professional Master’s degree in Hydrology, specializing in Ecohydrology, highlighting his interest in the environment and water systems. This academic journey laid the groundwork for his PhD studies in Climate Change and Disaster Risk Management, undertaken at the West African Science Service Center on Climate Change and Adapted Land Use (WASCAL) at the University of Lomé and the Hamburg University of Applied Sciences. His doctoral research, focusing on malaria risk modelling and community vulnerability in the context of climate change, signified his early commitment to impactful interdisciplinary science. Jean's education not only equipped him with deep scientific understanding but also empowered him with cross-border perspectives through training programs in Ghana, Kenya, Germany, and India. Fluent in both French and English, he emerged from his academic path with the tools necessary to address global health and climate challenges. His educational foundation was never merely about degrees—it was a launchpad for transformative research with a global vision and regional relevance, particularly tailored to West Africa’s unique climate and public health dynamics.

🧪 SCIENTIFIC CONTRIBUTIONS AND RESEARCH FOCUS

Gouvidé Jean Gbaguidi's research stands at the intersection of public health, climate science, and mathematical modelling. His doctoral thesis focused on malaria risk prediction and vulnerability assessment in Northern Benin, a region facing intense climate variability. By integrating climate data with health indicators, he offered pioneering insights into how malaria transmission dynamics are evolving under environmental stressors. His expertise is evident in multiple peer-reviewed publications that explore the use of remote sensing, vegetation indices, and geographic information systems to build predictive models for malaria outbreaks. A hallmark of his work is the practical application of advanced tools like EMOD (Epidemiological Model of Diseases), VECTRI, and satellite data, enabling more accurate forecasting of disease patterns. Jean's publications are not only scientifically robust but also socially relevant, addressing both the ecological and human dimensions of malaria vulnerability. His research has been widely recognized, appearing in top journals such as Scientific Reports, BMC Public Health, Malaria Journal, and One Health Outlook. His work emphasizes data-driven strategies that inform local interventions and regional health policies. Furthermore, his collaborative efforts with prominent scientists and institutions enhance the translational value of his research. Whether through bibliometric analysis of climate-related infectious diseases or scoping reviews on African educational curricula, Jean consistently seeks to bridge gaps between research, policy, and practice. His scientific focus is a model of integrated health-environment research that responds to the real-world challenges of disease in the Global South.

🧠 PROFESSIONAL ENDEAVORS AND TEACHING IMPACT

Jean’s career trajectory is marked by a blend of academic rigor and practical engagement. Since December 2024, he has served as a Main Instructor in mathematical modelling of malaria at Iba Der Thiam University in Senegal, where he trains future African scientists to use cutting-edge disease models like EMOD. This role is part of a broader regional initiative supported by the Bill and Melinda Gates Foundation. His teaching combines theory and practice, empowering students to simulate disease dynamics and assess intervention strategies in real-world scenarios. From July 2023 to July 2024, he also served as Project Manager at the Hamburg University of Applied Sciences, a role that honed his leadership and cross-cultural communication skills. Jean’s earlier roles included working at the Ministry of Energy, Water, and Mining in Benin, as well as participating in climate change training programs at UN institutions. These experiences reflect his multidisciplinary outlook and commitment to integrating science with policy. In addition to his academic responsibilities, Jean has engaged in several capacity-building programs across Africa, training in statistical tools like R and Python, as well as GIS and remote sensing technologies. These competencies have made him a valued contributor in regional training networks such as RUFORUM and UNITAR. Jean’s professional endeavors underscore a broader mission: to democratize access to advanced scientific tools and to mentor the next generation of African climate and health researchers. His impact is not only in publications but also in the classrooms and labs where future leaders are shaped.

📈 INNOVATIONS IN MALARIA MODELLING AND DATA SCIENCE

A defining feature of Jean Gbaguidi’s work is his innovation in malaria modelling. At the core of his PhD and ongoing research is the use of mathematical and statistical modelling to forecast malaria transmission under different climate change scenarios. He harnesses platforms like EMOD from the Institute for Disease Modeling and VECTRI to build simulation frameworks that incorporate climate, health, and socio-economic data. These models serve not only academic purposes but also provide actionable intelligence for public health officials and policy makers. His groundbreaking studies, such as the evaluation of the RTS,S/AS01 malaria vaccine using modelling approaches, illustrate how data science can predict health outcomes and optimize interventions in resource-limited settings. Jean’s ability to link large datasets—from satellite imagery to epidemiological records—makes his models both dynamic and adaptable. His training in QGIS, AVHRR-based vegetation health indices, and Climate Data Operator (CDO) software enables him to analyze multi-layered geospatial data with precision. Through interdisciplinary collaboration, his research has generated early warning systems for malaria outbreaks, a potentially life-saving tool for health ministries in vulnerable regions. By championing real-time analytics and predictive modelling, Jean is setting new benchmarks for how infectious disease risks are assessed and managed in the Global South. His contribution to the fusion of artificial intelligence, climate modelling, and public health surveillance represents a frontier in epidemiological research, emphasizing innovation for sustainable impact.

🏅 HONORS, PUBLICATIONS AND GLOBAL RECOGNITION

Jean Gbaguidi’s accomplishments are recognized through a distinguished body of scientific publications and international engagement. He has authored and co-authored over nine peer-reviewed articles in high-impact journals across climate science, public health, and infectious disease modelling. Among them are widely cited works such as “Potential Impact of Climate Change on the Transmission of Malaria in Northern Benin” and “Towards an Intelligent Malaria Outbreak Warning Model,” which have shaped discussions on climate-linked health vulnerabilities in West Africa. His work has also been accepted in reputable journals like One Health Outlook, Discover Social Science and Health, and Critical Public Health. Jean's participation in global conferences—including SYMMA 2024 in Senegal, the WRCP Open Science Conference in Rwanda, and scientific days at the University of Lomé—reflects his active role in the international research community. His scholarly contributions are coupled with recognition from training bodies like UNITAR, WHO, and RUFORUM, which have supported his professional development and capacity-building missions. These accolades are not just personal milestones; they serve as indicators of the global relevance and scientific merit of his work. Through collaborative research and publication with renowned academics such as Walter Leal Filho and Nikita Topanou, Jean has cemented his position as a trusted voice in the discourse on climate-resilient health systems. His rising ORCID profile and active presence in scholarly networks ensure that his research continues to influence both academic and policy domains on an international scale.

🌐 REGIONAL IMPACT AND CROSS-BORDER COLLABORATION

Gouvidé Jean Gbaguidi is not just a national asset for Benin but a regional thought leader in climate-health intersection research. His work bridges geographical, institutional, and disciplinary boundaries. By collaborating with institutions across Benin, Togo, Senegal, Germany, and Ghana, Jean has cultivated a network that amplifies the regional impact of his work. As a bilingual researcher fluent in English and French, he seamlessly integrates into diverse academic and policy environments. His leadership roles, including as a project manager and instructor in international contexts, reflect his capacity to translate research into cross-border dialogue and action. Jean is also actively engaged in pan-African training efforts, contributing to capacity building initiatives through RUFORUM, UNITAR, and university-led workshops. His focus on the vulnerability of West African communities to climate-sensitive diseases like malaria has made his work highly policy-relevant. Beyond research, he has contributed to curriculum assessments for African universities, evaluating how effectively educational institutions address the nexus of climate and health. These efforts aim to embed resilience thinking into Africa’s academic and policy frameworks. Jean’s regional vision is anchored in equity, sustainability, and scientific excellence. Whether through data-sharing platforms, multi-country modelling projects, or academic mobility, he champions an integrated African response to public health threats exacerbated by climate change. His work underscores that local problems require regional solidarity and innovative thinking—principles that Jean embodies both in practice and scholarship.

🔮 LEGACY, VISION AND FUTURE CONTRIBUTIONS

Looking ahead, Jean Gbaguidi’s trajectory points toward leadership in the global health and climate resilience landscape. With a recently defended PhD and a wealth of interdisciplinary experience, he is positioned to pioneer innovative policies, technologies, and frameworks that reduce disease burdens in climate-sensitive regions. His vision extends beyond academic publication to the co-creation of knowledge with communities, health authorities, and fellow researchers. He aims to scale early warning systems for malaria to other parts of sub-Saharan Africa, incorporating real-time environmental monitoring and artificial intelligence. Jean is also committed to shaping education by advocating for the integration of climate-health modules into African university curricula, ensuring that future generations of scientists are prepared for the challenges ahead. His aspiration includes mentoring young researchers across the continent, particularly those in underrepresented communities. By combining fieldwork, big data analytics, and participatory science, Jean envisions a future where policies are informed by robust, context-specific evidence. As he expands his collaborations and influences, his legacy will likely rest in his ability to translate complex science into tools that save lives, influence public policy, and build local capacities. His story is a testament to how a researcher from a small West African town can influence global dialogues on infectious disease, climate justice, and sustainable development. Jean Gbaguidi stands not only as a scholar but as a catalyst for change—ready to inspire and lead a new era of science-driven social transformation.

NOTABLE PUBLICATION

  • Title: Unleashing the power of intelligence: revolutionizing malaria outbreak preparedness with an advanced warning system in Benin, West Africa
    Authors: Gouvidé Jean Gbaguidi, Nikita Topanou, Walter Leal Filho, Komi Agboka, Guillaume K. Ketoh
    Journal: Archives of Public Health
    Publication Date: 2025-04-10

 

  • Title: Money for health: handling the costs of climate change to African health systems
    Authors: Walter Leal Filho, Gouvidé Jean Gbaguidi, Wassa Diarrassouba, Pim Martens
    Journal: Journal of Health, Population and Nutrition
    Publication Date: 2025-03-26

 

  • Title: Assessing vulnerability to malaria in the context of climate change: a comprehensive study in northern Benin, West Africa
    Authors: Gouvidé Jean Gbaguidi, Nikita Topanou, Walter Leal Filho, Guillaume K. Ketoh
    Journal: Discover Social Science and Health
    Publication Date: 2025-03-10

 

  • Title: The role of climatic changes in the emergence and re-emergence of infectious diseases: bibliometric analysis and literature-supported studies on zoonoses
    Authors: Walter Leal Filho, Gustavo J. Nagy, Gouvidé Jean Gbaguidi, Shlomit Paz, Maria Alzira Pimenta Dinis, Johannes M. Luetz, Ayyoob Sharifi
    Journal: One Health Outlook
    Publication Date: 2025-02-25

 

  • Title: Climate Change-Related Disaster Risk Events in Togo: A Systematic Review
    Authors: Massama-Esso P. Assiah, Gouvidé Jean Gbaguidi, Mouhamed Idrissou, Kossivi Hounake
    Journal: American Journal of Climate Change
    Publication Date: 2024

Derya Güzel Erdoğan – Plant Disease Modelling – Best Researcher Award

Posted on by Infectious

Derya Güzel Erdoğan - Plant Disease Modelling - Best Researcher Award

Sakarya University - Turkey

AUTHOR PROFILE

ORCID

🌱 EARLY ACADEMIC PURSUITS

DERYA GÜZEL ERDOĞAN's academic journey began with a solid foundation in medicine, earning her Bachelor's degree from Ondokuz Mayıs University in 2008. With a natural inclination toward physiological sciences, she advanced to complete her specialization at Ankara University's Department of Physiology in 2013. Her doctoral thesis, which investigated the effects of intermittent hypoxia on the cardiac HIF/VEGF pathway in Type 1 Diabetes Mellitus, reflects her early commitment to research at the intersection of cardiology and molecular biology. Her work during this period foreshadowed a career defined by meticulous inquiry and innovation in experimental physiology. Through rigorous scientific training, Erdoğan honed both her research and clinical skills, preparing herself to tackle complex questions in pathophysiology, especially those related to inflammation, ischemia-reperfusion injury, and metabolic diseases. These early experiences provided a deep understanding of translational medicine and laid the groundwork for her future exploration of cellular signaling and therapeutic interventions.

🧪 RESEARCH EXCELLENCE AND FOCUS

ERDOĞAN’s research portfolio spans an impressive range of physiological and biomedical topics, with a notable emphasis on inflammation, oxidative stress, ischemia-reperfusion injury, and angiogenesis. Her pioneering studies delve into the molecular mechanisms of diseases such as psoriatic arthritis, schizophrenia, thyroid cancer, and myocardial infarction. Her work frequently involves investigating angiogenetic molecules like VEGF, HIF, and HO-1, aiming to understand their roles in inflammation and tissue regeneration. She has been principal investigator or collaborator in numerous TÜBİTAK and university-funded projects, showcasing her ability to translate fundamental physiology into potential clinical applications. Among her distinguished research themes is the modulation of systemic inflammation and oxidative damage using phytochemicals like hesperidin, apocynin, and rosmarinic acid. Her studies provide essential insights into how plant-based compounds can serve as protective agents in various disease models. Erdoğan’s ongoing research continues to shed light on complex physiological interactions, particularly in the domains of neuroendocrinology, reproductive physiology, and immune responses.

🧑‍🏫 PROFESSIONAL ENDEAVORS

As a dedicated academic, Derya Güzel Erdoğan has served in key roles across Sakarya University’s Faculty of Medicine, notably within the Department of Physiology. Rising from a research assistant at Ankara University to an assistant professor and later an associate professor at Sakarya, she exemplifies academic leadership. From 2015 to 2018, she was Head of the Physiology Department, reflecting trust in her administrative and academic capabilities. Erdoğan has mentored multiple postgraduate theses, guiding students in experimental models of rheumatoid arthritis, angiogenesis, and inflammatory signaling pathways. Her pedagogical commitment is also evident in her contributions to physiology education and her co-authorship of scientific book chapters on topics like exercise physiology, calcium homeostasis, and neurohormonal signaling. Her teaching, firmly grounded in current research, bridges theory and practice, encouraging students to critically engage with emerging physiological paradigms. She has also collaborated across disciplines, contributing to physiology’s intersection with psychiatry, endocrinology, and cardiology.

🧬 SCIENTIFIC CONTRIBUTIONS AND COLLABORATIONS

Erdoğan has authored or co-authored over 40 articles in international peer-reviewed journals, consistently contributing to high-impact fields like psychoneuroendocrinology, reproductive physiology, and inflammation research. Her collaborative work often integrates biochemical analysis, histopathological techniques, and behavioral models, enabling multifaceted exploration of disease states. Whether examining neurotrophic factors in bipolar disorder or the interplay of Klotho and BDNF in cannabinoid users, her contributions reflect a robust interdisciplinary approach. Several of her studies address systemic disorders with a molecular lens, such as the NILCO pathway in thyroid cancer and the vascular implications of cytokines in rheumatoid arthritis. Erdoğan’s involvement in congresses and symposia underscores her role as a knowledge disseminator, where she presents cutting-edge findings and engages in global scientific discourse. She has also been a key figure in investigating the therapeutic value of natural compounds, championing their role in experimental models of arthritis, ischemia, and oxidative injury.

🏆 ACCOLADES AND RECOGNITION

Throughout her career, Erdoğan has earned multiple awards acknowledging her contributions to science and academia. Notably, she received the second-place research award at the 10th International Congress on Psychopharmacology in 2018, recognizing her innovative exploration of neuroendocrine markers in psychiatric disorders. She was also honored in Sakarya University’s “Medicine of the Future III” poster competition, placing third for her work in experimental physiology. These accolades reflect both her commitment to scientific rigor and the broader impact of her research on physiological and clinical sciences. Her ability to connect laboratory findings with potential clinical applications makes her a standout figure in experimental medicine. Moreover, her active membership in the Turkish Physiological Sciences Society attests to her engagement in advancing national scientific standards. Erdoğan’s recognition is not only a testament to her technical expertise but also to her perseverance, mentorship, and scholarly influence within the biomedical research community.

🌍 IMPACT AND INFLUENCE

Derya Güzel Erdoğan’s research has influenced several domains of physiology and medical science, particularly in understanding the interface between oxidative stress, inflammation, and tissue repair. Her findings on neuroplasticity, metabolic disorders, and reproductive physiology have been cited by researchers seeking to develop novel interventions for complex pathologies. Her emphasis on integrative physiology—connecting molecular signals to systemic outcomes—offers a model for translational research. By examining how dietary, hormonal, and pharmacological agents influence disease processes, Erdoğan contributes to a better understanding of how to prevent and manage chronic inflammatory and degenerative conditions. Her role in experimental designs that utilize animal models to simulate human diseases has equipped many young researchers with the tools and methodologies needed to pursue independent scientific inquiry. Her influence extends beyond publications—she shapes research ethics, inspires collaborative science, and provides a blueprint for future scientists eager to bridge laboratory findings with real-world health challenges.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

As Erdoğan continues to explore new frontiers in experimental physiology, her legacy is being defined by both scientific depth and mentorship. She is currently engaged in national projects funded by TÜBİTAK, focusing on the interplay of gut microbiota, cardiovascular remodeling, and hormonal balance in experimental disease models. Her foresight in selecting impactful research topics ensures that her work remains both relevant and visionary. Erdoğan’s legacy will be marked not only by her publications and grants but also by the many students and colleagues she has mentored, who carry forward her passion for translational physiology. With a firm grounding in empirical rigor and a vision oriented toward holistic understanding of disease mechanisms, she is poised to make continued contributions to personalized medicine, especially in the context of inflammation, neurobiology, and endocrine function. Her future research promises to further unravel the complex interplay between physiological systems, leading to better-targeted and more effective therapeutic strategies.

NOTABLE PUBLICATION

  • Title: Effects of different doses of Ganoderic Acid A on nociceptive behaviour and inflammatory parameters in polyarthritic mice rheumatoid arthritis model
    Authors: Erdogan, Derya Guzel; Demir, Aysenur; Baylan, Huseyin; Budak, Ozcan; Cokluk, Erdem; Tanyeri, Pelin
    Journal: Scientific Reports

 

  • Title: Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response
    Authors: Isik, Musab; Kose, Fadime; Ozbayer, Cansu; Budak, Ozcan; Kaya, Rumeysa Keles; Erdogan, Derya Guzel; Demirci, Mehmet Arif; Doganay, Songul; Bagci, Cahit
    Journal: Probiotics and Antimicrobial Proteins

 

  • Title: Relationship between klotho, neurotrophic factors (BDNF, NGF, GDNF) and cognitive functions in patients with bipolar disorder
    Authors: Celebi, Zeynep; Yazici, Esra; Erdogan, Derya Guzel; Davutoglu, Onur; Yazici, Ahmet Bulent
    Journal: BMC Psychiatry

 

  • Title: The protective effects of hesperidin pretreatment on kidney and remote organs against renal ischemia-reperfusion injury
    Authors: Karacaer, C.; Erdogan, D. G.; Tanyeli, A.; Baylan, H.; Eraslan, E.; Guler, M. C.; Polat, E.; Comakli, S.
    Journal: European Review for Medical and Pharmacological Sciences

 

  • Title: An Overview of Ischemia-Reperfusion Injury: Review on Oxidative Stress and Inflammatory Response
    Authors: Guler, Mustafa Can; Tanyeli, Ayhan; Akdemir, Fazile Nur Ekinci; Eraslan, Ersen; Sebin, Saime Ozbek; Erdogan, Derya Guzel; Nacar, Tuncer
    Journal: The Eurasian Journal of Medicine